In the eighth and final segment of this roundtable series, the panel discusses future directions in the field of NSCLC.
Dr. Liu shares why the meeting is a key chance for connections, collaborations, and conversations about the latest data.
In the seventh segment of this roundtable series, the panel discusses how path CR affects postoperative management.
In the sixth segment of this roundtable series, the panel discusses neoadjuvant versus perioperative approaches.
Perioperative Immunotherapy in NSCLC: Evolving Data, Surgical Planning, and Real-World Collaboration
In the fifth segment of this roundtable series, the panel discusses CheckMate 77T, CheckMate 816, and more. In the fourth segment of this roundtable series, the panel discusses multidisciplinary, comprehensive collaboration.
In the final part of this roundtable series, the panel discusses what the future may hold for NSCLC treatment and surgery.
In the eighth part of this roundtable series, the panel discusses how to minimize the risk of NSCLC recurrence after surgery.
In the second segment of this roundtable series, the panel discusses the importance of safe sampling in biomarker testing.
In the third segment of this roundtable series, the panel discusses resectability and multimodal treatment plans.
In the first segment of this roundtable series, the panel discusses the initial steps in NSCLC diagnosis and treatment.